Tablet-based Cognitive Behavioral Intervention for Older Adults With Arthritis Fatigue
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this project is to pilot test a long-term effect of Tab-G (tablet-based cognitive behavioral group education intervention). The investigators will evaluate the effect of Tab-G, relative to usual care group, on (a) daily steps, (b) fatigue level, (c) self-efficacy and (d) quality of life. Tab-G participants will receive 4 weekly CBT-based group education focusing on shared goal setting and mutual reinforcement in a group with 5 members. The outcomes will be measured baseline, week 4 (intervention completion) and week 8 (follow-up). The investigators hypothesize that older adults receiving Tab-G will have greater improvements on outcomes compared to those receiving usual care at week 4, the intervention completion and at week 8 follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 21, 2021
CompletedFirst Submitted
Initial submission to the registry
March 7, 2021
CompletedFirst Posted
Study publicly available on registry
March 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedMay 9, 2023
May 1, 2023
2.3 years
March 7, 2021
May 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
daily steps
daily step counts measured by an accelerometer
24 hours
BRICS NINR PROMIS Fatigue Short Form 6a
self-reported fatigue scale measuring both the experience of fatigue and the interference of fatigue on daily activities. Scores can range from 6 to 30, with higher scores indicating greater fatigue.
past 1 week
Self-Efficacy for Managing Chronic Disease 6-Item Scale
self-reported self-efficacy scale. Scores can range from 6 to 60, with higher scores indicating higher self-efficacy.
24 hours
Quality of Life-Rheumatoid Arthritis Scale
self-reported perception of quality of life. Scores can range from 8 to 80 with higher scores indicating greater quality of life.
past 4 weeks
Study Arms (2)
Tab-G (tablet-based group CBT education)
EXPERIMENTALTab-G participants will receive 4 weekly CBT(cognitive behavioral therapy)-based group learning sessions to encourage a simple walking activity through videoconferencing meetings in a group of 5 members. The educational materials emphasize shared goal setting and mutual reinforcement.
Usual care group
NO INTERVENTIONA usual care group will receive general arthritis management education. Participant are instructed to maintain usual activity during the study period.
Interventions
Participants receive a tablet preloaded with Tab-G application and an accelerometer.
Eligibility Criteria
You may qualify if:
- diagnosis of osteoarthritis or rheumatoid arthritis;
- presence of greater than minimal fatigue scoring ≥13 (T-score\>55) on the Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v1.0-Fatigue 6a; and
- having Wi-Fi at home
You may not qualify if:
- currently engaging in regular exercise;
- non-ambulatory or presence of a condition that would limit the ability to walk (e.g., foot deformity, lower extremity joint surgery in past 6 months, stroke, severe chronic obstructive pulmonary disease, etc.); and
- delirium, dementia, or any conditions indicating deteriorating cognitive status as determined by the Mini-Cog.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Massachusetts
Amherst, Massachusetts, 01003, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeungok Choi, PhD
University of Massachusetts, Amherst
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
March 7, 2021
First Posted
March 11, 2021
Study Start
January 21, 2021
Primary Completion
April 30, 2023
Study Completion
April 30, 2023
Last Updated
May 9, 2023
Record last verified: 2023-05